Literature DB >> 317153

The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.

S A Cairns, E J Acheson, C L Corbett, S Dosa, N P Mallick, W Lawler, G Williams.   

Abstract

In 11 patients who presented with apparently idiopathic glomerular disease the antinuclear factor (ANF) was absent initially but was eventually detected during observation extending over 6 years. In 4 patients a diagnosis of systemic lupus erythematosus (SLE) has now been made and the disease treated. Of the remaining 7, 2 had conditions known to be associated with a positive ANF, and in 4, drug therapy induced the ANF. Clinical features, complement studies and measurement of anti-DNA antibody were of value in distinguishing those patients with SLE from the others.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 317153      PMCID: PMC2425745          DOI: 10.1136/pgmj.55.648.723

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

1.  Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.

Authors:  J S Cameron; M H Lessof; C S Ogg; B D Williams; D G Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  V E POLLAK; C L PIRANI; F D SCHWARTZ
Journal:  J Lab Clin Med       Date:  1964-04

3.  THE SPECTRUM OF LUPUS NEPHRITIS.

Authors:  M L SIMENHOFF; J P MERRILL
Journal:  Nephron       Date:  1964       Impact factor: 2.847

4.  S.L.E. nephritis with positive tests for antibodies against native D.N.A. but negative tests for antinuclear antibodies.

Authors:  G Lindstedt; P A Lundberg; G Westberg; B Kaijser
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

5.  Laboratory tests in rheumatic diseases.

Authors:  W V Epstein
Journal:  Med Clin North Am       Date:  1977-03       Impact factor: 5.456

6.  Serum immune complexes and disease activity in lupus nephritis.

Authors:  R J Levinsky; J S Cameron; J F Soothill
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  The treatment of lupus nephritis by methyl prednisolone pulse therapy.

Authors:  S Dosa; S A Cairns; W Lawler; N P Mallick; I N Slotki
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

8.  Immunopathology of early and clinically silent lupus nephropathy.

Authors:  T Cavallo; W R Cameron; D Lapenas
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Lupus nephritis. Clinical course as related to morphologic forms and their transitions.

Authors:  D S Baldwin; M C Gluck; J Lowenstein; G R Gallo
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

Review 10.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more
  2 in total

1.  Lupus-like membranous nephropathy: Is it lupus or not?

Authors:  Ramin Sam; Amit Joshi; Sam James; Kuang-Yu Jen; Firouz Amani; Peter Hart; Melvin M Schwartz
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

2.  A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset.

Authors:  Takehisa Yamada; Fumiaki Itagaki; Sae Aratani; Sayuri Kawasaki; Kousuke Terada; Koji Mugishima; Tetsuya Kashiwagi; Akira Shimizu; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2019-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.